DSpace at RU >

Search Results

Results 1-50 of 80.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	European expert opinion on the management of invasive candidiasis in adults	Kullberg, B.J.; Verweij, P.E.; Akova, M.; Arendrup, M.C.; Bille, J.; Calandra, T.; Cuenca-Estrella, M.; Herbrecht, R.; Jacobs, F.; Kalin, M.; Kibbler, C.C.; Lortholary, O.; Martino, P.; Meis, J.F.; Munoz, P.; Odds, F.C.; Pauw, B.E. de; Rex, J.H.; Roilides, E.; Rogers, T.R.; Ruhnke, M.; Ullmann, A.J.; Uzun, O.; Vandewoude, K.; Vincent, J.L.; Donnelly, J.P.
	2010	A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.	Maertens, J.A.; Madero, L.; Reilly, A.F.; Lehrnbecher, T.; Groll, A.H.; Jafri, H.S.; Green, M.; Nania, J.J.; Bourque, M.R.; Wise, B.A.; Strohmaier, K.M.; Taylor, A.F.; Kartsonis, N.A.; Chow, J.W.; Arndt, C.A.; Pauw, B.E. de; Walsh, T.J.
	2009	Timely intervention for invasive fungal disease: should the road now lead to the laboratory instead of the pharmacy?	Pauw, B.E. de; Donnelly, J.P.
	2008	A perspective on liposomal amphotericin B (AmBisome)	Richardson, M.; Pauw, B.E. de
	2008	Present situation in the treatment of invasive fungal infection.	Pauw, B.E. de; Picazo, J.J.
	2008	Erythrocyte vesiculation: a self-protective mechanism?	Willekens, F.L.A.; Werre, J.M.; Groenen-Dopp, Y.A.; Roerdinkholder-Stoelwinder, B.; Pauw, B.E. de; Bosman, G.J.C.G.M.
	2008	Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.	Segal, B.H.; Herbrecht, R.; Stevens, D.A.; Ostrosky-Zeichner, L.; Sobel, J.; Viscoli, C.; Walsh, T.J.; Maertens, J.; Patterson, T.F.; Perfect, J.R.; Dupont, B.; Wingard, J.R.; Calandra, T.; Kauffman, C.A.; Graybill, J.R.; Baden, L.R.; Pappas, P.G.; Bennett, J.E.; Kontoyiannis, D.P.; Cordonnier, C.; Viviani, M.A.; Bille, J.; Almyroudis, N.G.; Wheat, L.J.; Graninger, W.; Bow, E.J.; Holland, S.M.; Kullberg, B.J.; Dismukes, W.E.; Pauw, B.E. de
	2008	Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.	Pauw, B.E. de; Walsh, T.J.; Donnelly, J.P.; Stevens, D.A.; Edwards, J.E.; Calandra, T.; Pappas, P.G.; Maertens, J.; Lortholary, O.; Kauffman, C.A.; Denning, D.W.; Patterson, T.F.; Maschmeyer, G.; Bille, J.; Dismukes, W.E.; Herbrecht, R.; Hope, W.W.; Kibbler, C.C.; Kullberg, B.J.; Marr, K.A.; Munoz, P.; Odds, F.C.; Perfect, J.R.; Restrepo, A.; Ruhnke, M.; Segal, B.H.; Sobel, J.D.; Sorrell, T.C.; Viscoli, C.; Wingard, J.R.; Zaoutis, T.; Bennett, J.E.
	2007	Principles of antimicrobial therapy in the transplant recipient.	Pauw, B.E. de; Rubin, R.H.
	2007	The value of randomized clinical trials for daily clinical practice.	Pauw, B.E. de; Rubin, R.H.
	2007	Individualization in the management of fungal disease in the transplant recipient.	Pauw, B.E. de; Rubin, R.H.
	2007	Prophylaxis and aspergillosis--has the principle been proven?	Pauw, B.E. de; Donnelly, J.P.
	2007	Comparison of two highly discriminatory molecular fingerprinting assays for analysis of multiple Aspergillus fumigatus isolates from patients with invasive aspergillosis.	Valk, H.A. de; Meis, J.F.G.M.; Pauw, B.E. de; Donnelly, J.P.; Klaassen, C.H.W.
	2007	Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.	Greene, R.E.; Schlamm, H.T.; Oestmann, J.W.; Stark, P.; Durand, C.; Lortholary, O.; Wingard, J.R.; Herbrecht, R.; Ribaud, P.; Patterson, T.F.; Troke, P.F.; Denning, D.W.; Bennett, J.E.; Pauw, B.E. de; Rubin, R.H.
	2007	Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements.	Wiefferink, A.; Weerwind, P.W.; Heerde, W.L. van; Teerenstra, S.; Noyez, L.; Pauw, B.E. de; Brouwer, R.M.H.J.
	2006	Treatment of malignant haematological diseases: from maximally tolerated to minimally required?	Pauw, B.E. de
	2006	Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy.	Pauw, B.E. de; Rubin, R.H.
	2006	Increasing fungal infections in the intensive care unit	Pauw, B.E. de
	2006	Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection.	Almyroudis, N.G.; Kontoyiannis, D.P.; Sepkowitz, K.A.; Pauw, B.E. de; Walsh, T.J.; Segal, B.H.
	2006	Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study.	Pauw, B.E. de; Sable, C.A.; Walsh, T.J.; Lupinacci, R.J.; Bourque, M.R.; Wise, B.A.; Nguyen, B.Y.; DiNubile, M.J.; Teppler, H.
	2006	Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.	Anaissie, E.; Segal, B.H.; Graybill, J.R.; Arndt, C.; Perfect, J.R.; Kleinberg, M.; Pappas, P.; Benjamin, D.; Rubin, R.; Aberg, J.A.; Adderson, E.E.; Adler-Shohet, F.C.; Akan, H.; Akova, M.; Almyroudis, N.G.; Alexander, B.D.; Andes, D.; Arrieta, A.; Baddley, J.W.; Barron, M.A.; Belzberg, H.; Boucher, H.W.; Boyce, T.G.; Casadevall, A.; Chandrasekar, P.H.; Cleary, J.D.; Cordonnier, C.; Cornely, O.A.; Cuenca-Estrella, M.; Daly, J.S.; Daoura, N.; Denning, D.W.; Pauw, B.E. de; Repentigny, L. de; Dignani, M.C.; Dismukes, W.; Donnelly, J.P.; Donowitz, G.; Dupont, B.; Drusano, G.; Ellis, M.; Espinel-Ingroff, A.; Fishman, J.A.; Fleming, R.; Forrest, G.; Ghannoum, M.A.; Goldman, M.; Grazziutti, M.; Greene, J.N.; Greenberg, R.N.; Gubbins, P.O.; Hadley, S.; Herbrecht, R.; Hiemenz, J.W.; Hope, W.; Hospenthal, D.R.; Husain, S.; Ito, J.I.; Jacobson, R.M.; Johnson, M.; Keating, M.R.; Kett, D.H.; Knapp, K.; Kontoyiannis, D.P.; Krcmery, V.; Larsen, R.; Laverdiere, M.; Ljungman, P.; Lortholary, O.; Maertens, J.; Marriott, D.; Mattiuzzi, G.; McGinnis, M.R.; Morris, M.; Nucci, M.; Odds, F.C.; Pankey, G.A.; Patterson, T.; Pfaller, M.; Razonable, R.R.; Reboli, A.C.; Rinaldi, M.G.; Roberts, G.D.; Rodriguez-Tudela, J.L.; Rotstein, C.; Ruhnke, M.; Schuster, M.; Shoham, S.; Sia, I.G.; Siebel, N.; Silviera, F.; Singh, N.; Sobel, J.; Solomkin, J.S.; Sorrell, T.C.; Steinbach, W.J.; Temesgen, Z.; Tortorano, A.; Vartivarian, S.
	2005	More echinocandins - better therapies?	Pauw, B.E. de
	2005	Stratégies thérapeutiques antifongiques en hématologie	Pauw, B.E. de
	2005	Evolution in the treatment of hematologic malignancies.	Pauw, B.E. de
	2005	Microbiologic consequences of new approaches to managing hematologic malignancies.	Blijlevens, N.M.A.; Donnelly, J.P.; Pauw, B.E. de
	2005	Caspofungin versus liposomal amphotericin B for empirical therapy.	Walsh, T.J.; Donowitz, G.; Pauw, B.E. de
	2005	Between over- and undertreatment of invasive fungal disease.	Pauw, B.E. de
	2005	Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant	Blijlevens, N.M.A.; Donnelly, J.P.; Pauw, B.E. de
	2005	Should the consensus guidelines' specific criteria for the diagnosis of invasive fungal infection be changed?	Pauw, B.E. de; Patterson, T.F.
	2005	Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients.	Blijlevens, N.M.A.; Donnelly, J.P.; Pauw, B.E. de
	2005	Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.	Lutgens, L.C.; Blijlevens, N.M.A.; Deutz, N.E.; Donnelly, J.P.; Lambin, P.; Pauw, B.E. de
	2005	A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients.	Blijlevens, N.M.A.; Donnelly, J.P.; Naber, A.H.J.; Schattenberg, A.V.M.B.; Pauw, B.E. de
	2005	Verbeterde diagnostiek van invasieve aspergillose en systematische controle bij patiënten met een verhoogd risico	Verweij, P.E.; Donnelly, J.P.; Die, C.E. van; Blijlevens, N.M.A.; Kullberg, B.J.; Pauw, B.E. de
	2004	Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia	Walsh, T.J.; Teppler, H.; Donowitz, G.; Maertens, J.A.; Baden, L.R.; Dmoszynska, A.; Cornely, O.A.; Bourque, M.R.; Lupinacci, R.J.; Sable, C.A.; Pauw, B.E. de
	2004	Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity	Donnelly, J.P.; Pauw, B.E. de
	2004	EORTC Invasive Fungal Infections Group. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.	Oude Lashof, A.M.L.; Bock, R. de; Herbrecht, R.; Pauw, B.E. de; Krcmery, V.; Aoun, M.; Akova, M.; Cohen, J.; Siffnerova, H.; Egyed, M.; Ellis, M.; Marinus, A.; Sylvester, R.J.; Kullberg, B.J.
	2004	Preventative use of antifungal drugs in patients treated for cancer.	Pauw, B.E. de
	2004	Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius--a pathogen or passenger?	Levenga, H.; Donnelly, P.; Blijlevens, N.M.A.; Verweij, P.E.; Shirango, H.T.; Pauw, B.E. de
	2004	Measuring mucosal damage induced by cytotoxic therapy.	Blijlevens, N.M.A.; Land, B. van 't; Donnelly, J.P.; Rabet, L. M'; Pauw, B.E. de
	2004	An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.	Oude Lashof, A.M.L.; Bock, R. de; Herbrecht, R.; Pauw, B.E. de; Krcmery, V.; Aoun, M.; Akova, M.; Cohen, J.; Siffnerova, H.; Egyed, M.; Ellis, M.; Marinus, A.; Sylvester, R.J.; Kullberg, B.J.
	2004	Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.	Offner, F.; Krcmery, V.; Boogaerts, M.; Doyen, C.; Engelhard, D.; Ribaud, P.; Cordonnier, C.; Pauw, B.E. de; Durrant, S.; Marie, J.P.; Moreau, P.; Guiot, H.F.L.; Samonis, G.; Sylvester, R.J.; Herbrecht, R.
	1997	Controversies in management of candidiasis in neutropenic patients treated for malignant diseases: new versus old or better versus worse	Pauw, B.E. de; Anaissie, E.
	1997	Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient	Pauw, B.E. de; Raemaekers, J.M.M.; Schattenberg, A.V.M.B.; Donnelly, J.P.
	1997	Een besliskundige analyse van twee strategieën voor de diagnostiek en therapie van invasieve aspergillose (abstract)	Verweij, P.E.; Severens, J.L.; Donnelly, J.P.; Meis, J.F.G.M.; Pauw, B.E. de
	1997	Clinical Infectious Diseases	Severens, J.L.; Donnelly, J.P.; Meis, J.F.G.M.; Vries Robbé, P.F., de; Pauw, B.E. de; Verweij, P.E.
	1997	Controversies in the antibacterial treatment of patients with neutropenia: a matter of comprehension or apprehension?	Pauw, B.E. de; Donnelly, J.P.
	1997	Practical modalities for prevention of fungal infections in cancer patients	Pauw, B.E. de
	1997	International conference for the development of a consensus on the management and prevention of severe candidal infections	Edwards, J.E.; Bodey, G.P.; Bowden, R.A.; Büchner, T.; Pauw, B.E. de; Filler, S.G.; Ghannoum, M.A.; Glauser, M.; Herbrecht, R.; Kauffman, C.A.; Kohno, S.; Martino, P.; Meunier, F.; Mori, H.; Pfaller, M.A.; Rex, J.H.; Rogers, T.R.; Rubin, R.H.; Solomkin, J.; Viscoli, C.; Walsh, T.J.; White, M.
	1997	Clostridium septicum sepsis and neutropenic enterocolitis in a patient treated with intensive chemotherapy for acute myeloid leukemia	Pouwels, M.J.M.; Donnelly, J.P.; Raemaekers, J.M.M.; Verweij, P.E.; Pauw, B.E. de
	1997	Een besliskundige analyse van twee strategieën voor de diagnostiek en therapie van invasieve aspergillose	Verweij, P.E.; Severens, J.L.; Donnelly, J.P.; Vries Robbé, P.F., de; Pauw, B.E. de; Meis, J.F.G.M.

1 2 next